Semler Scientific Inc SMLR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SMLR is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $26.62
- Day Range
- $25.78–26.60
- 52-Week Range
- $22.82–53.38
- Bid/Ask
- $25.92 / $26.15
- Market Cap
- $182.88 Mil
- Volume/Avg
- 21,736 / 82,097
Key Statistics
- Price/Earnings (Normalized)
- 8.73
- Price/Sales
- 3.05
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 92
- Website
- http://www.semlerscientific.com
Comparables
Valuation
|
Metric
|
SMLR
|
EMBC
|
LDDD
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.73 | 3.45 | 329.88 |
Price/Book Value | 2.55 | — | — |
Price/Sales | 3.05 | 0.56 | 21.94 |
Price/Cash Flow | 8.30 | 5.39 | 107.84 |
Price/Earnings
SMLR
EMBC
LDDD
Financial Strength
|
Metric
|
SMLR
|
EMBC
|
LDDD
|
|---|---|---|---|
Quick Ratio | 10.21 | 1.55 | 0.84 |
Current Ratio | 10.64 | 2.20 | 0.85 |
Interest Coverage | — | 1.59 | — |
Quick Ratio
SMLR
EMBC
LDDD
Profitability
|
Metric
|
SMLR
|
EMBC
|
LDDD
|
|---|---|---|---|
Return on Assets (Normalized) | 33.98% | 12.52% | 69.66% |
Return on Equity (Normalized) | 38.29% | — | — |
Return on Invested Capital (Normalized) | 34.96% | 30.00% | — |
Return on Assets
SMLR
EMBC
LDDD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pdmymsbn | Tdskz | $185.5 Bil | |
SYK
| Stryker Corp | Sxlvvxcrl | Zhq | $128.2 Bil | |
MDT
| Medtronic PLC | Lwpsgzpg | Fxndpps | $106.7 Bil | |
BSX
| Boston Scientific Corp | Lsxrcgy | Czddl | $99.0 Bil | |
DXCM
| DexCom Inc | Xghvklcbmp | Nnkp | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Kgzhfdwyz | Tjmbh | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Czkcwfmll | Flcv | $24.9 Bil | |
ALGN
| Align Technology Inc | Nqnllbgl | Qkkykvq | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Jphgqwykn | Fgxmdv | $18.9 Bil | |
PODD
| Insulet Corp | Pqhdkzxf | Jnbjdl | $11.7 Bil |